Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 7;27(21):7649.
doi: 10.3390/molecules27217649.

Efficient Synthesis of Fluorescent Coumarins and Phosphorous-Containing Coumarin-Type Heterocycles via Palladium Catalyzed Cross-Coupling Reactions

Affiliations

Efficient Synthesis of Fluorescent Coumarins and Phosphorous-Containing Coumarin-Type Heterocycles via Palladium Catalyzed Cross-Coupling Reactions

Rumen Lyapchev et al. Molecules. .

Abstract

Quantum-chemical calculations on the spectral properties of some aryl substituted 3-phosphonocoumarins were performed, and the effect of the substituents in the aryl moiety was evaluated. The structures possessing promising fluorescent properties were successfully synthesized via Suzuki and Sonogashira cross-coupling. The synthetic protocol was also applied for the phosphorous chemoisomer of 3-phosphonocoumarin, 1,2-benzoxaphosphorin, and their carboxylate analogues. The optical properties of the arylated and alkynylated products were experimentally determined. The obtained quantum-chemical and experimental results give the possibility for a fine tuning of the optical properties of phosphorous-containing coumarin systems by altering the substituent at its C-6 position.

Keywords: 1,2-benzoxaphosphorin; 3-phosphonocoumarin; DFT calculations; Pd-catalyzed reactions; Sonogashira reaction; Suzuki reaction; coumarin-3-carboxylates; cross-coupling; fluorescence; photophysical properties.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Suzuki reaction of 5-bromo-2-hydroxybenzaldehyde 1 with phenylboronic acid.
Scheme 2
Scheme 2
Knoevenagel condensation.
Scheme 3
Scheme 3
Suzuki coupling.
Figure 1
Figure 1
Pd-complexes used as catalyst in the studied reaction.
Scheme 4
Scheme 4
Suzuki coupling—optimizing the conditions.
Figure 2
Figure 2
ORTEP representation with thermal ellipsoids 40%—Crystal Data for C19H19O5P (M = 358.333 g/mol): monoclinic, space group P21/n (no. 14), a = 13.6869(9) Å, b = 8.5123(5) Å, c = 14.9033(9) Å, α = 90°, β = 90.726(2)°, γ = 90°, V = 1736.20(19) Å3, Z = 4, T = 133.00 K, μ(MoKα) = 0.185 mm−1, Dcalc = 1.371 g/cm3, 26,401 reflections measured (4.06° ≤ 2Θ ≤ 55.84°), 4155 unique (Rint = 0.0591, Rsigma = 0.0405) which were used in all calculations. The final R1 was 0.0390 (I > 2σ(I)) and wR2 was 0.1092 (all data). The crystallographic data could be found in the Supplementary Materials.
Scheme 5
Scheme 5
Suzuki coupling of 6-bromo-3-phosphonocoumarin 5.
Scheme 6
Scheme 6
Palladium-catalyzed arylation of 6-bromocoumarin-3-carboxylates 8a,b.
Scheme 7
Scheme 7
Palladium-catalyzed arylation of ethyl 6-bromo-2-ethoxybenzo[e][1,2]oxaphosphorine-3-carboxylate 6.
Scheme 8
Scheme 8
Palladium-catalyzed alkynylation of 3-substituted coumarin species—Sonogashira coupling.
Figure 3
Figure 3
Normalized fluorescent spectra of the phenyl substituted derivatives.
Figure 4
Figure 4
UV-VIS and normalized fluorescence spectra of 3a-b, 12a, and 12d phosphonocoumarins in acetonitrile.
Figure 5
Figure 5
UV-VIS and normalized fluorescence spectra in acetonitrile: (a) series of ethyl coumarin-3-carboxylates compounds 9a–e, 12b; (b) series of methyl coumarin-3-carboxylates compounds 10a–e; (c) series of ethyl 2-ethoxybenzo[e][1,2]oxaphosphorine-3-carboxylate 11a–d.
Figure 5
Figure 5
UV-VIS and normalized fluorescence spectra in acetonitrile: (a) series of ethyl coumarin-3-carboxylates compounds 9a–e, 12b; (b) series of methyl coumarin-3-carboxylates compounds 10a–e; (c) series of ethyl 2-ethoxybenzo[e][1,2]oxaphosphorine-3-carboxylate 11a–d.
Figure 6
Figure 6
Normalized fluorescence spectra in acetonitrile for derivatives bearing para-methoxyphenyl groups.
Figure 7
Figure 7
Fluorescence intensity in acetonitrile according to the pH: (a) coumarin 3a (c = 10−5 M) behavior in sulfuric acid, 1N; (b) coumarin 3c (c = 10−5 M) behavior in sulfuric acid, 1N; (c) coumarin 3a (c = 10−5 M) behavior in NaOH, 1N; (d) coumarin 3c (c = 10−5 M) behavior in NaOH, 1N. The green arrow is showing the changing of the fluorescence intensity depending on the H+ concentration.
Figure 7
Figure 7
Fluorescence intensity in acetonitrile according to the pH: (a) coumarin 3a (c = 10−5 M) behavior in sulfuric acid, 1N; (b) coumarin 3c (c = 10−5 M) behavior in sulfuric acid, 1N; (c) coumarin 3a (c = 10−5 M) behavior in NaOH, 1N; (d) coumarin 3c (c = 10−5 M) behavior in NaOH, 1N. The green arrow is showing the changing of the fluorescence intensity depending on the H+ concentration.

Similar articles

References

    1. Koleva A.I., Petkova-Yankova N.I., Nikolova R.D. Synthesis and Chemical Properties of 3-Phosphonocoumarins and 1,2-Benzoxaphosphorins as Precursors for Bioactive Compounds. Molecules. 2019;24:2030. doi: 10.3390/molecules24112030. - DOI - PMC - PubMed
    1. Bhatia R., Pathania S., Singh V., Rawalet R.K. Metal-catalyzed synthetic strategies toward coumarin derivatives. Chem. Heterocycl. Comp. 2018;54:280–291. doi: 10.1007/s10593-018-2262-6. - DOI
    1. Szwaczko K. Coumarins Synthesis and Transformation via C–H Bond Activation—A Review. Inorganics. 2022;10:23. doi: 10.3390/inorganics10020023. - DOI
    1. Annunziata F., Pinna C., Dallavalle S., Tamborini L., Pinto A. An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities. Int. J. Mol. Sci. 2020;21:4618. doi: 10.3390/ijms21134618. - DOI - PMC - PubMed
    1. Cheke R.S., Patel H.M., Patil V.M., Ansari I.A., Ambhore J.P., Shinde S.D., Kadri A., Snoussi M., Adnan M., Kharkar P.S., et al. Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery. Antibiotics. 2022;11:566. doi: 10.3390/antibiotics11050566. - DOI - PMC - PubMed

LinkOut - more resources